Print PDF https://www.medpagetoday.com/infectiousdisease/covid19/104713 The FDA has granted full approvalopens in a new tab or window to nirmatrelvir-ritonavir (Paxlovid) for treating adult outpatients with mild to moderate COVID-19 who are at risk for severe disease, the agency announced on Thursday. Post navigation Respiratory Protection Program Development VIDEO SASBA-st andrews sexual behavioral assessment scale
